A detailed history of Salvus Wealth Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Salvus Wealth Management, LLC holds 4,913 shares of ABT stock, worth $565,142. This represents 0.35% of its overall portfolio holdings.

Number of Shares
4,913
Previous 4,710 4.31%
Holding current value
$565,142
Previous $489,000 14.52%
% of portfolio
0.35%
Previous 0.34%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$100.07 - $118.13 $20,314 - $23,980
203 Added 4.31%
4,913 $560,000
Q2 2024

Jul 16, 2024

BUY
$100.73 - $112.44 $58,020 - $64,765
576 Added 13.93%
4,710 $489,000
Q1 2024

Apr 12, 2024

BUY
$109.52 - $120.96 $65,821 - $72,696
601 Added 17.01%
4,134 $469,000
Q4 2023

Jan 08, 2024

BUY
$90.19 - $110.4 $270 - $331
3 Added 0.08%
3,533 $388,000
Q3 2023

Oct 10, 2023

BUY
$95.53 - $114.62 $14,425 - $17,307
151 Added 4.47%
3,530 $341,000
Q2 2023

Jul 13, 2023

SELL
$100.78 - $112.29 $13,403 - $14,934
-133 Reduced 3.79%
3,379 $368,000
Q1 2023

Apr 11, 2023

BUY
$96.86 - $114.01 $28,864 - $33,974
298 Added 9.27%
3,512 $355,000
Q4 2022

Jan 18, 2023

SELL
$95.06 - $111.52 $39,830 - $46,726
-419 Reduced 11.53%
3,214 $0
Q3 2022

Oct 12, 2022

BUY
$96.76 - $112.03 $1,451 - $1,680
15 Added 0.41%
3,633 $352,000
Q2 2022

Jul 11, 2022

SELL
$102.07 - $123.37 $75,021 - $90,676
-735 Reduced 16.88%
3,618 $393,000
Q1 2022

Apr 11, 2022

BUY
$114.02 - $139.04 $74,455 - $90,793
653 Added 17.65%
4,353 $515,000
Q4 2021

Jan 19, 2022

BUY
$115.53 - $141.46 $73,823 - $90,392
639 Added 20.88%
3,700 $521,000
Q3 2021

Oct 05, 2021

BUY
$116.66 - $129.06 $82,711 - $91,503
709 Added 30.14%
3,061 $362,000
Q2 2021

Jul 09, 2021

BUY
$105.79 - $124.53 $248,818 - $292,894
2,352 New
2,352 $276,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Salvus Wealth Management, LLC Portfolio

Follow Salvus Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salvus Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Salvus Wealth Management, LLC with notifications on news.